CompletedPhase 1NCT00493961
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
Studying Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Seminara B Stephanie, MDMassachusetts General Hospital
- Intervention
- gonadotropin releasing hormone (GnRH)(drug)
- Enrollment
- 27 enrolled
- Eligibility
- 18-65 years · MALE
- Timeline
- 1999 – 2009
Study locations (1)
- Massachusetts General Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00493961 on ClinicalTrials.govOther trials for Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT05971836The Molecular Basis of Inherited Reproductive DisordersStephanie B. Seminara, MD
- ACTIVE NOT RECRUITINGNCT04733274Patient and Healthcare Professional Views on Genetic/Genomic Information and TestingBoston College
- RECRUITINGNCT01601171Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or PalateCentre Hospitalier Universitaire Vaudois